![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Abstract
Purpose: Tumour lactate levels have been shown to correlate with high radioresistance in tumour models in vivo. The study aimed to evaluate the impact of pathophysiological extracellular lactate concentrations and acidosis on the in vitro survival and radioresponse of various cancer cell lines.
Materials and methods: HCT-116, HT29 (colorectal) and FaDu (HNSCC) carcinoma cells were studied. Lactate release rates were determined, and expression of the monocarboxylate transporter MCT1 and its cofactor CD147 were monitored by immunofluorescence and flow cytometry. Colony formation was compared for cells exposed to 20 mM exogenous lactate, acidosis (pH 6.4) and lactate plus acidosis relative to control and dose response curves (0.5–10 Gy) were documented.
Results: All cell lines expressed MCT1 and CD147 and showed comparable lactate release rates. High lactate levels and acidosis slightly decreased HCT-116 colony forming capacity. This effect was neither additive nor did it affect radioresponse. Clonogenic survival of HT29 cells, however, was critically reduced in a lactate-enriched or acidic milieu and a synergistic effect was observed. Here, both conditions enhanced radiosensitivity. Exogenous lactate also impaired colony formation of FaDu cells but acidosis was ineffective. This cell line was more susceptible to irradiation under lactate exposure independent of pH.
Conclusions: Tumour cell behaviour and radioresponse in a lactate environment is multifaceted. The consideration of lactate accumulation as a parameter affecting radiotherapeutic intervention and as a target for new therapeutic strategies is interesting but requires extended mechanistic studies.
Acknowledgements
The authors gratefully acknowledge the excellent technical assistance of Ms Melanie Huether. We thank the Institute of Clinical Chemistry and Laboratory Medicine (TU Dresden, Germany) for determination of lactate concentrations in cell culture supernatants. This work was supported by the German Federal Ministry of Education and Research (BMBF) through grant 01ZZ0502 (LAKS), by the Faculty of Medicine Carl Gustav Carus, TU Dresden (MedDrive - CD) and by the German Research Foundation (DFG) through grants Ba 1433/5 (MB) and Mu 576/14 (WMK). OncoRay is funded by the BMBF in the program ‘Center for Innovation Competence’.
Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.
